Innospec Inc. (IOSP) Shares Bought by Hsbc Holdings PLC

Hsbc Holdings PLC boosted its stake in Innospec Inc. (NASDAQ:IOSP) by 24.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 65,831 shares of the specialty chemicals company’s stock after buying an additional 12,888 shares during the quarter. Hsbc Holdings PLC owned approximately 0.27% of Innospec worth $4,066,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in IOSP. MetLife Investment Advisors LLC increased its stake in shares of Innospec by 53.0% during the 3rd quarter. MetLife Investment Advisors LLC now owns 17,299 shares of the specialty chemicals company’s stock worth $1,328,000 after purchasing an additional 5,996 shares during the last quarter. Alpha Windward LLC acquired a new position in shares of Innospec during the 4th quarter worth $385,000. BlueMountain Capital Management LLC increased its stake in shares of Innospec by 281.7% during the 3rd quarter. BlueMountain Capital Management LLC now owns 17,535 shares of the specialty chemicals company’s stock worth $1,346,000 after purchasing an additional 12,941 shares during the last quarter. Stone Ridge Asset Management LLC acquired a new position in shares of Innospec during the 3rd quarter worth $375,000. Finally, Bank of New York Mellon Corp increased its stake in shares of Innospec by 3.6% during the 3rd quarter. Bank of New York Mellon Corp now owns 351,777 shares of the specialty chemicals company’s stock worth $26,999,000 after purchasing an additional 12,101 shares during the last quarter. Institutional investors own 93.00% of the company’s stock.

In related news, VP Philip John Boon sold 1,528 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $83.39, for a total value of $127,419.92. Following the transaction, the vice president now directly owns 38,383 shares in the company, valued at approximately $3,200,758.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick Williams sold 7,030 shares of the firm’s stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $84.16, for a total transaction of $591,644.80. Following the completion of the transaction, the chief executive officer now owns 186,579 shares in the company, valued at $15,702,488.64. The disclosure for this sale can be found here. Insiders sold a total of 28,984 shares of company stock worth $2,382,501 over the last quarter. 2.22% of the stock is currently owned by company insiders.

NASDAQ:IOSP opened at $82.65 on Friday. Innospec Inc. has a 1 year low of $53.07 and a 1 year high of $86.53. The company has a current ratio of 2.24, a quick ratio of 1.40 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $2.02 billion, a P/E ratio of 17.11 and a beta of 1.33.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, February 19th. The specialty chemicals company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.35 by $0.27. Innospec had a net margin of 5.76% and a return on equity of 14.34%. The business had revenue of $395.00 million for the quarter. Research analysts forecast that Innospec Inc. will post 5 EPS for the current year.

Several research analysts have recently commented on IOSP shares. BidaskClub upgraded shares of Innospec from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 23rd. Zacks Investment Research lowered shares of Innospec from a “buy” rating to a “hold” rating in a research note on Friday, January 4th. Finally, ValuEngine lowered shares of Innospec from a “buy” rating to a “hold” rating in a research note on Tuesday, November 27th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $88.50.

TRADEMARK VIOLATION WARNING: “Innospec Inc. (IOSP) Shares Bought by Hsbc Holdings PLC” was first posted by PressOracle and is owned by of PressOracle. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://pressoracle.com/news/2019/03/17/innospec-inc-iosp-shares-bought-by-hsbc-holdings-plc.html.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.

Read More: Systematic Risk

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.